Search

Search Constraints

You searched for: Author/Creator Desai, Akshay S

Search Results

1. Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. (22nd March 2023)

2. Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF). (3rd June 2014)

3. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Issue 10024 (19th March 2016)

4. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. (26th December 2017)

5. Dapagliflozin for heart failure according to body mass index: the DELIVER trial . (27th August 2022)

6. Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. (22nd December 2020)

7. Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. Issue 5 (May 2017)

8. Effects of dapagliflozin in DAPA-HF according to background heart failure therapy. (28th March 2020)

9. Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial. Issue 12 (December 2022)

10. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Issue 10304 (11th September 2021)